Nishat Sultana is designated as Laboratory Coordinator at Institute for Developing Science and Health Initiatives (ideSHi). She joined ideSHi in November 2021. She received her BSc and MS degrees in Biochemistry and Molecular Biology from the University of Dhaka in 2010 and 2011 respectively. After completing her MS, she joined Research and Development (R&D) at Renata Pharmaceuticals Ltd. Afterwards, she moved to R&D at Biotech facility of Incepta Pharmaceuticals and worked there until February 2020. During her 9 years’ experience, she received training on SAP as a part of lab management, Molecular Diagnostic Kit development (China), LC-MS MS and FACS (India). During her time at Incepta, she was the lead of Molecular Analysis unit where development of dipstick assay (POCT) for detection of Cholera and Typhoid had been completed. Throughout her career, she gained experience in some sophisticated techniques including ELISA, Dot Blot, HPLC, IR, UV Spectrophotometer, SDS-PAGE, Agarose gel electrophoresis, monoclonal Antibody separation and purification and Bioassay. She attended the Annual Meeting of ASM 2014, presented a poster at the US-Japan Conference 2014, and delivered an oral and poster presentation at the ASM Conference 2015 held in the USA. She received an award for her oral presentation in the DRDC Conference 2016.

Her multifaceted talents are demonstrated through her extra-curricular involvement. She was an anchor and organizing member of the 1st Biochemistry Olympiad. She won the 1st prize in essay and story-writing, and 2nd prize in recitation in a competition held by the University of Dhaka. In addition, she worked as an anchor on Ekushey Television, conducted multiple programs at BTV, and acted as a part-time editor of Prothom Alo. 

At ideSHi, she oversee the Quality Management System (QMS) of laboratory to maintain Good Laboratory Practice (cGLP), Good Documentation Practice (cGDP) properly as well as she is one of the core team of CRO (Contract Research Organization). She is also responsible for laboratory service division especially biochemical and molecular biology based testing.

She has been acknowledged for the advanced training of QMS, Equipment Management System and Biosafety from the certification of Fondation Meriux, France. She has been awarded for the ‘Aspiring Lab Manager’ from P.A.C.E.

She is actively involved in several research projects, which include COVID-19 vaccine response, prevention of HPV infection and cervical cancer, thalassemia awareness, and free carrier screening program, Dengue serotype study, Ovarian cancer study by BRCA mutation sequencing analysis, Genomic surveillance of SARS-CoV-2 and nationwide capacity building across Bangladesh, Performance Evaluation of Developed Bangasure Multiplex RT-PCR Kit for SARS-CoV-2 Detection in Bangladesh as a Co-investigator. She worked at different clinical trial with the team of CRO for PK & safety study of Adalimumab, PD, PK and Efficacy study of Typhoid vaccine, Safety and efficacy study of Ranibizumab at ideSHi. As a researcher, Nishat Sultana is energetic, dynamic and enthusiastic about her field. Her research interest lies in molecular diagnosis, point of care testing, biochemical analysis, epidemiology and public health. 

ü  Development of a Simple, Peripheral-Blood-Based Lateral-Flow Dipstick Assay for Accurate Detection of Patients with Enteric Fever. Clin Vaccine Immunol. 2016; 23 (5):403-409. Published 2016 May 6. doi:10.1128/CVI.00690-15, Khan IH, Sayeed MA, Sultana N, et al.

ü  Development of a new dipstick (Cholkit) for rapid detection of Vibrio cholerae O1 in acute watery diarrheal stools. PLoS Negl Trop Dis. 2018; 12 (3):e0006286. Published 2018 Mar 14. doi:10.1371/journal.pntd.0006286, Sayeed MA, Islam K, Hossain M, et al.

ü  Field evaluation of a locally produced rapid diagnostic test for early detection of cholera in Bangladesh. PLoS Negl Trop Dis. 2019; 13 (1):e0007124. Published 2019 Jan 31. doi:10.1371/journal.pntd.0007124, Islam MT, Khan AI, Sayeed MA, et al.

ü  Evaluation of a Locally Produced Rapid Diagnostic Test (RDT) for Detection of Cholera in Bangladesh, Khan IH, Sayeed MA, Sultana N, et al.

ü  Kulsum, U., Azad, K., Washif, M., Hossain, M., Sultana, N., Hossain, I., Ahmed, F., Rahman, R., Muktadir, A., Muktadir, H. and Karim, M., 2022. Pharmacokinetic and safety analysis of biosimilar adalimumab in healthy volunteers in Bangladesh. [Preprint]https://doi.org/10.21203/rs.3.rs-2372748/v1.

ü  Non Inferiority Trial of Locally Manufactured Rabies Vaccine ‘Rabix-VC’ in Bangladesh ClinicalTrials.gov Identifier: NCT04715867

ü  Screening of Thalassemia Carriers, Hemoglobin Variants, and Comparison of Hematological Parameters between Children of Bangladesh and Forcibly Displaced Myanmar Nationals.